Company |
SDS, Inc. (SDS) was founded in 1990 with a bold approach
to modern medical diagnostics: to develop reliable and affordable rapid tests for
infectious diseases that collect, process, and analyze samples in a few simple steps,
using self- contained, disposable devices.
|
| |
After
years of work and at great expense, the strategy has paid off. SDS now has a diagnostic
tool that can easily and reliably detect selected diseases not only in the
physicians office or hospital laboratory, but outside laboratory settings, in a
matter of minutes. That tool is the SDS HemaStrip capillary blood sampler, the
core technology in the companys rapid tests for HIV infection (HemaStrip HIV
1/2) and for infection with Helicobacter pylori (HemaStrip
StatSimple pylori), an infection of the stomach which can cause ulcers
and digestive upset. |
| |
Extensive
studies conducted by SDS around the world, in conjunction with governmental agencies,
universities, and private and public laboratories indicate SDS assays meet global
standards in sensitivity and specificity. In addition to diagnosing HIV and H. pylori
infection, the SDS team has shown that the HemaStrip device can be developed
into a tool to diagnose other diseases where prompt detection and treatment is critical,
such as hepatitis, malaria, and tuberculosis. |
| |
In
addition to the HemaStrip capillary sampler, SDS has developed other advanced
sampling devices which allow the physician, care provider, and others who do testing to
obtain specimens rapidly and easily. OmniSwab® is a patented, ejectable-head swab
which can obtain a sample from the inside of the cheek for genetic testing, eliminating
the need for drawing blood. OmniSal® is a patented device for the collection,
storage, and shipment of oral fluid (saliva). Oral fluid collected with OmniSal®
has been used to test for HIV and hepatitis infection, drugs of abuse, and cotenine. |
 |
| >Meeting
the Global need for Fast and Easy HIV Testing |
SDS is positioned to meet the developing worlds urgent demand for rapid and
affordable tests for infectious disease. The World Health Organization (WHO) has estimated
that over 90% of new HIV infections are taking place in Asia, Africa and parts of Latin
America. Asia itself is considered a major "hotbed" of HIV infection, with one
of the fastest growing rates of heterosexually transmitted HIV. SDS is dedicated to
introducing methods of rapid, on-the-spot diagnosis into these markets. Making these tests
available in these areas will save lives.
Most HIV tests require a clinical laboratory setting, with sophisticated and expensive
equipment, constant electricity and refrigeration, and a professional staff. Many HIV
tests also take hours to produce results, in a series of carefully timed steps. Testing
with slow, capital-intensive assays, or other so-called "rapid tests" which are
messy, time consuming, or which require blood drawing, has been the developing
worlds only real option for measuring HIV infection.
until Now! |
 |
| Fast,
easy H. pylori test for US and overseas |
SDS has developed and recently received United States FDA approval for its rapid antibody
test for Helicobacter pylori (H. Pylori), a bacteria believed to cause up to 80% of peptic
ulcers and gastric cancers. Roughly a third of the population in the United States is
estimated to have been exposed to the bacteria. SDS believes there is no approved H.
pylori diagnostic product on the market that is as simple and easy to use with results in
only 15 minutes.
|

|